Wilfried Roeloffzen

Search results

• 2024

  Successful Desensitization to Isatuximab in a Patient With Refractory Multiple Myeloma and Indolent Systemic Mastocytosis Reply to: Anaphylactic Shock due to Isatuximab and Successful Desensitization

  Hutten, E. M., Roeloffzen, W. W. H., Lambeck, A. J. A., van den Born-Bondt, T., Oude Elberink, H. N. G. & van de Ven, A. A. J. M., Jun-2024, In: Journal of investigational allergology and clinical immunology. 34, 3, p. 214-216 3 p.

  Research output: Contribution to journal › Letter › Academic › peer-review
  1 Citation (Scopus)
• 2022

  Increased mortality risk in multiple-myeloma patients with subsequent malignancies: a population-based study in the Netherlands

  Brink, M., Minnema, M. C., Visser, O., Levin, M.-D., Posthuma, E. F. M. W., Broijl, A., Sonneveld, P., van der Klift, M., Roeloffzen, W. W. H., Westerman, M., van Rooijen, C. R., Geerts, P. A. F., Zweegman, S., van de Donk, N. W. C. J. & Dinmohamed, A. G., 15-Mar-2022, In: Blood cancer journal. 12, 3, 4 p., 41.

  Research output: Contribution to journal › Letter › Academic › peer-review

  Open Access

  File
  7 Citations (Scopus)

  68 Downloads (Pure)